pharmaphorum
FEBRUARY 18, 2021
Nektar Therapeutics is waiting on multiple data readouts for its lead drug bempegaldesleukin paired with strategic partner Bristol-Myers Squibb’s checkpoint inhibitor Opdivo, but that hasn’t stopped it signing up to test the drug with rival Keytruda from Merck & Co. .
STAT News
AUGUST 17, 2022
National Institutes of Health failed to ensure that results of roughly half of clinical trials funded by the agency — both those conducted by its own scientists and outside researchers — were reported to a federal database during a recent two-year period, a new government review has found.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 16, 2020
Adding Eli Lilly’s rheumatoid arthritis drug Olumiant (baricitinib) and Gilead Sciences’ remdesivir reduces recovery time in COVID-19 patients compared to remdesivir alone, says a new trial. ACTT-2 used a 4mg dose of the drug, which wasn’t approved by the FDA on safety grounds.
pharmaphorum
AUGUST 25, 2020
The first patients have been dosed in a trial of two AstraZeneca antibodies, collectively known as AZD7442, that are being developed to both treat and prevent coronavirus infections. The phase 1 trial – funded by the US government – will take place in the UK and will test the safety of AZD7442 and its pharmacokinetic profile.
Advarra
JUNE 9, 2022
Designing a DCT comes with certain challenges of course, particularly when proposing to utilize outside groups or locations for the trial. Funding, sponsorship, tasks to be conducted, and the legal structures of entities may impact sites and the study overall. Why do Funding and Sponsorship Matter?
The Pharma Data
JANUARY 15, 2021
Steven Nathan, senior researcher on the new trial. There are, however, drugs for another form of pulmonary hypertension, known as pulmonary arterial hypertension. Over 16 weeks, patients randomly assigned to use the drug were able to improve their performance on a six-minute treadmill walk.
pharmaphorum
NOVEMBER 10, 2022
Elliott informed those in attendance that for the next five years, with about £5 billion in funding for pipelines across a network of research and institute centres in clinical trials, that the aim is for everyone to live a life free of cancer. And in the UK over 30% of clinical trials funded has one European partner at least.
Expert insights. Personalized for you.
98 
Let's personalize your content